| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 10 |
| 1 | METHOTREXATE | 10 |
| 2 | METHOTREXATE SODIUM | 10 |
| 3 | LEFLUNOMIDE | 9 |
| 4 | PREDNISOLONE | 9 |
| 5 | PREDNISOLONE ORAL | 9 |
| 6 | PREDNISOLONE ORAL SOLUTION | 9 |
| 7 | SILDENAFIL CITRATE | 9 |
| 8 | SULFASALAZINE | 9 |
| 9 | EZETIMIBE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DIAZOXIDE | 1 | 0.0014 |
| 1 | PURIXAN | 1 | 0.0013 |
| 2 | IVABRADINE | 8 | 0.0012 |
| 3 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 2 | 0.0004 |
| 4 | DARIDOREXANT | 1 | 0.0004 |
| 5 | GOLIMUMAB | 4 | 0.0003 |
| 6 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 7 | CEFUROXIME AXETIL | 1 | 0.0003 |
| 8 | TOFACITINIB CITRATE | 3 | 0.0002 |
| 9 | SILDENAFIL POWDER, | 7 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | Aminosalicylate [EPC] | 10 | 0.0001 |
| 2 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 3 | Dietary Cholesterol Absorption Inhibitor [EPC] | 8 | 0.0001 |
| 4 | Antirheumatic Agent [EPC] | 9 | 0.0001 |
| 5 | Antisense Oligonucleotide [EPC] | 1 | 0.0001 |
| 6 | Angiotensin Converting Enzyme Inhibitor [EPC] | 9 | 0.0001 |
| 7 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 7 | 0.0001 |
| 9 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 1 | 0.0000 |